This Product Theater Presentation focuses on providing education to Frontline Providers on the topics of CAD risk assessment, the various testing modalities available, the value of SPECT MPI, and the Appropriate Use Criteria (AUC).

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.



David Wolinsky, MD, FACC, MASNC

Head of Nuclear Cardiology
Cleveland Clinic, Florida

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.